Allakos


Allakos is developing therapeutic antibodies that that selectively target eosinophils and mast cells, cells that play a significant role in many diseases

Employees

51-200

Links


Org chart

Robert Alexander
Chief Executive Officer
Collapse
Craig Paterson
Chief Medical Officer
Robyn Seitzinger
Vice President of Sales
Karen Flick
General Counsel
Vince Anicetti
Scientific Advisor - Manufacturing Advisory Board
Alex Schwartz
Vice President, Strategic Finance and Investor Relations
Eric Schaefer
Vice President, Chief Accountant